Heparin-induced hyperkalemia is a potentially life-threatening side effect that requires careful monitoring and prevention. By understanding the risks and taking steps to mitigate them, healthcare providers can minimize the risk of hyperkalemia and ensure safe anticoagulation therapy.
| Patient Factor | Clinical Scenario | |----------------|-------------------| | | CKD (especially stages 4–5) | | Diabetes mellitus | Hyporeninemic hypoaldosteronism | | Older age (>60 years) | Age-related decline in renin/aldosterone | | Use of other potassium-elevating drugs | ACEi, ARB, K+-sparing diuretics (spironolactone, eplerenone, amiloride), NSAIDs, beta-blockers, trimethoprim, calcineurin inhibitors | | High heparin doses | Therapeutic anticoagulation > prophylactic doses | | LMWH use | Less common than UFH, but still reported | heparin and hyperkalemia
Heparin is a commonly used anticoagulant medication that helps prevent blood clots in patients undergoing surgery, dialysis, or receiving treatment for certain medical conditions. While heparin is generally considered safe, it can cause a potentially life-threatening side effect: hyperkalemia. While heparin is generally considered safe, it can
Seite erstellt in 0.072 Sekunden mit 23 Abfragen.